Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
Condition(s):Allergic RhinitisLast Updated:February 22, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Allergic RhinitisLast Updated:February 22, 2024Not yet recruiting
Condition(s):Primary DysmenorrheaLast Updated:February 22, 2024Not yet recruiting
Condition(s):Prostatic Hyperplasia, Benign; Erectile DysfunctionLast Updated:February 20, 2024Not yet recruiting
Condition(s):Moderate Pain; Severe PainLast Updated:February 20, 2024Not yet recruiting
Condition(s):Type 2 Diabetes MellitusLast Updated:June 2, 2023Not yet recruiting
Condition(s):Female Pattern BaldnessLast Updated:February 16, 2024Not yet recruiting
Condition(s):PainLast Updated:February 20, 2024Completed
Condition(s):Aphthous StomatitisLast Updated:February 20, 2024Recruiting
Condition(s):Allergic RhinitisLast Updated:February 16, 2024Not yet recruiting
Condition(s):Primary DysmenorrheaLast Updated:February 16, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.